Cadila Healthcare informs about press release

10 Nov 2017 Evaluate

Cadila Healthcare has informed about a Press Release dated November 10, 2017 titled ‘Zydus announces regulatory approval of Lipaglyn (Saroglitazar Magnesium) in Mexico’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

915.45 13.30 (1.47%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×